Factor VII/IgG1-Fc anticancer gene therapy (Yale/Sidney Kimmel)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFactor VII/IgG1-Fc anticancer gene therapy (Yale/Sidney Kimmel)
Drug Alias Nameadenoviral gene therapy (Yale/Sidney Kimmel)adenoviral gene therapy (Yale/Sidney Kimmel)
ClassificationBiologics
Mechanisms of ActionCoagulation factor VII modulators
TargetsCoagulation factor VII
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSidney Kimmel Cancer CenterYale University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A